![](https://www.rickilewis.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBOW5FQVE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--d7b427c8393abfcc5599ce83c243a94fdee50eb8/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lKYW5CbFp3WTZCa1ZVT2hSeVpYTnBlbVZmZEc5ZmJHbHRhWFJiQjJrQzRBRnBBdUFCIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--8baca904b64d4717b73c68c7de6fd7f38b987845/box_butters.jpeg)
Early on in the pandemic, a worse clinical scenario for the male of the species emerged. A study published mid-May from Italian researchers offered early statistics from the WHO and Chinese scientists: a death rate of 1.7% for women and 2.8% for men. Then Hong Kong hospitals reported that 15% of females and 32% of males with COVID-19 needed intensive care or had died.
In July a Perspective published in Nature Reviews Immunology from researchers at Johns Hopkins University and the University of Montreal noted a similar "male bias" for other viral infections, including SARS and MERS. By then, the wide community testing in South Korea and data from the U.S. indicated 1.5-fold higher mortality for men for COVID-19. The pattern repeated in 38 countries, for patients of all ages.
Now a new study published in Nature Communications expands the increased risk for those who have only one X chromosome
To continue reading, go to my DNA Science blog at Public Library of Science.